ACP
SBBP

Acuta Capital Partners’s Strongbridge Biopharma plc. SBBP Stock Holding History

Acuta Capital Partners’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,063,747
Closed -$4.51M – 69
2016
Q1 		$4.51M Buy
1,063,747
+84,840
+9% +$382K 2.52% 14
2015
Q4 		$6.87M Buy
+978,907
New +$7.03M 3.28% 10

Other funds holding SBBP

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
TAF
Tredje AP-fonden Se-111 91 Stockholm, Sweden $18.3B AUM 27.14% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Acuta Capital Partners's SBBP Position: Q2 2016 in Review

Acuta Capital Partners sold out of Strongbridge Biopharma plc. (SBBP) in Q2 2016, closing a stake of 1,063,747 shares — an estimated $4.51M sold.

Acuta Capital Partners first reported a position in SBBP in Q4 2015 and held it in 2 quarters. The position peaked at $6.87M in Q4 2015. 14 funds tracked by Wall St. Rank hold SBBP as of Q2 2016.

  • Acuta Capital Partners reported no remaining Strongbridge Biopharma plc. position as of Q2 2016 after selling out during the quarter.
  • Acuta Capital Partners sold 1,063,747 Strongbridge Biopharma plc. shares in Q2 2016, an estimated $4.51M.
  • Acuta Capital Partners first reported a position in Strongbridge Biopharma plc. in Q4 2015 and held it in 2 quarters.
  • Acuta Capital Partners's Strongbridge Biopharma plc. position peaked at $6.87M in Q4 2015.
  • 14 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q2 2016.

Based on Acuta Capital Partners's 13F filing for Q2 2016, filed 15 Aug 2016.